Detalhe da pesquisa
1.
The prevalence of Fabry disease in a statewide chronic kidney disease cohort - Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study.
BMC Nephrol;
23(1): 169, 2022 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35505287
2.
The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
BMC Nephrol;
21(1): 58, 2020 02 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32087678
3.
Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples.
Clin Chem;
62(1): 279-86, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26585924
4.
Demographic changes in Australia's regulated health professions: 6-year trends.
Aust Health Rev;
47(2): 246-253, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36914203
5.
Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
Orphanet J Rare Dis;
15(1): 10, 2020 01 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31931840
6.
Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool.
Clin Chim Acta;
450: 6-10, 2015 Oct 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26232157